BIOS — Biosenic SA Share News
0.000.00%
Last trade - 00:00Brief: Bone Therapeutics 9-Month Operating Loss Narrows To 8.1 Million Euros
Brief: Bone Therapeutics H1 Total Operating Income Down At 1.7 Million Euros
Brief: Bone Therapeutics Successfully Raises EUR 8.5 Mln
Brief: Bone Therapeutics To Raise Capital Through Private Placement Of New Shares And Issuance Of Non-Dilutive Subordinated Bonds
Brief: Bone Therapeutics’ ALLOB Meets Primary Endpoints In Phase IIa Study
Brief: Bone Therapeutics To Present Data At TERMIS European Chapter Meeting 2019
Brief: Bone Therapeutics Cash Balance At End Q1 Was 7.13 Million Euros
Brief: Bone Therapeutics To Highlight Osteogenic Properties Of Proprietary Allogenic
Brief: Bone Therapeutics FY Operating Loss Lowers To EUR 11.5 Mln
Brief: Bone Therapeutics Announces 2019 Business Outlook
Brief: Bone Therapeutics Announces Conclusions From Interim Analysis Of Phase III PREOB Study
Brief: Bone Therapeutics Q3 Operating Loss Widens To 8.96 Million Euros
Brief: Bone Therapeutics Announces Results Of First Efficacy Study Of JTA-004
Advisory: News alert on Bone Therapeutics mid-term target withdrawn
Europe Research Roundup: British American Tobacco, GVC Holdings, Prudential
Brief: Bone Therapeutics SA Announces Final Results From Phase I/IIa Study
Brief: Bone Therapeutics End-H1 Cash And Cash Equivalents Of EUR 9.10 Million
Brief: Bone Therapeutics Q1 Cash Balance Of 10.42 Million Euros
Brief: Bone Therapeutics FY Net Loss Down At 12.8 Million Euros